Published in Clin Microbiol Infect on August 21, 2007
Traditional Medicinal Plant Extracts and Natural Products with Activity against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases. Evid Based Complement Alternat Med (2011) 2.45
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis (2013) 2.08
Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev (2009) 1.71
Implications of oral biofilms in medically at risk persons. J Biomed Res (2012) 0.98
The role of fluoride in the preventive management of dentin hypersensitivity and root caries. Clin Oral Investig (2012) 0.96
Changing clinical features of odontogenic maxillofacial infections. Clin Oral Investig (2009) 0.86
Antimicrobial efficacy of the combinations of Acacia nilotica, Murraya koenigii L. sprengel, Eucalyptus hybrid and Psidium guajava on primary plaque colonizers. J Basic Clin Pharm (2014) 0.83
Oral complications and management strategies for patients undergoing cancer therapy. ScientificWorldJournal (2014) 0.83
Supervised versus non-supervised implementation of an oral health care guideline in (residential) care homes: a cluster randomized controlled clinical trial. BMC Oral Health (2010) 0.81
Effectiveness of supervised implementation of an oral health care guideline in care homes; a single-blinded cluster randomized controlled trial. Clin Oral Investig (2012) 0.79
The role of unfinished root canal treatment in odontogenic maxillofacial infections requiring hospital care. Clin Oral Investig (2012) 0.79
Malva sylvestris Inhibits Inflammatory Response in Oral Human Cells. An In Vitro Infection Model. PLoS One (2015) 0.78
Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans. J Bacteriol (2013) 0.78
Role of aqueous extract of morinda citrifolia (Indian noni) ripe fruits in inhibiting dental caries-causing streptococcus mutans and streptococcus mitis. J Dent (Tehran) (2014) 0.77
A novel method for sampling the microbiota from the oral mucosa. Clin Oral Investig (2008) 0.76
Dental students' knowledge of characteristics and management of oral complications of cancer therapy. Support Care Cancer (2013) 0.76
Investigation of the oral infections and manifestations seen in patients with advanced cancer. Pak J Med Sci (2013) 0.75
Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Concerns about Potential Application in Dental Practice. Int J Med Sci (2016) 0.75
Improving the oral health of residents with intellectual and developmental disabilities: an oral health strategy and pilot study. Eval Program Plann (2014) 0.75
Functional foods/ingredients and oral mucosal diseases. Eur J Nutr (2012) 0.75
The oral-systemic disease connection: a retrospective study. Clin Oral Investig (2016) 0.75
Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives. Front Cell Infect Microbiol (2017) 0.75
Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol (1982) 2.86
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 (1997) 2.62
Relationship between periodontal infections and systemic disease. Clin Microbiol Infect (2007) 2.56
Human B cell development. II. Subpopulations in the human fetus. J Immunol (1985) 1.67
Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst (1994) 1.56
Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 (1997) 1.51
Periodontal disease and systemic health: current status. Aust Dent J (2009) 1.48
The effect of a triclosan-containing dentifrice on the progression of periodontal disease in an adult population. J Clin Periodontol (2003) 1.44
The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease. J Periodontal Res (1979) 1.34
Chemokines in human periodontal disease tissues. Clin Exp Immunol (2001) 1.28
Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med (2002) 1.26
Immunopathogenesis of oral lichen planus. J Oral Pathol Med (1990) 1.21
Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res (1994) 1.21
Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res (2005) 1.19
Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun (2002) 1.12
c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma. Hum Genet (1988) 1.12
Antibody responses of Porphyromonas gingivalis infected gingivitis and periodontitis subjects. Oral Dis (1995) 1.10
Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol (2006) 1.09
IL-4- and IL-6-producing cells in human periodontal disease tissue. J Oral Pathol Med (1994) 1.08
Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis (2007) 1.07
Possible mechanisms involved in the immunoregulation of chronic inflammatory periodontal disease. J Dent Res (1987) 1.07
Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol (1999) 1.07
Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06
Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol (2006) 1.05
The immunopathogenesis of periodontal disease. Aust Dent J (2009) 1.03
Abnormal prostatic cells in ejaculates from men with prostatic cancer--a preliminary report. Br J Urol (1996) 1.02
Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol (1993) 1.01
The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production. J Invest Dermatol (1985) 1.00
Is there a role for triclosan/copolymer toothpaste in the management of periodontal disease? Br Dent J (2009) 1.00
Anti-P. gingivalis response correlates with atherosclerosis. J Dent Res (2007) 1.00
The possible pathogenesis of gingival recession. A histological study of induced recession in the rat. J Clin Periodontol (1976) 1.00
Distribution of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia in an Australian population. J Clin Periodontol (2001) 1.00
Enzyme differentiation of lymphocyte subpopulations in sections of human lymph nodes, tonsils and periodontal disease. Clin Exp Immunol (1978) 0.99
Capnocytophaga canimorsus septicemia: fifth report of a cat-associated infection and five other cases. Eur J Clin Microbiol Infect Dis (1995) 0.99
Ante-dependence modeling in a longitudinal study of periodontal disease: the effect of age, gender, and smoking status. J Periodontol (2000) 0.98
Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int (1998) 0.98
T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect Immun (2001) 0.97
Identification of cells expressing T and p28,33 (Ia-like) antigens in sections of human lymphoid tissue. Clin Exp Immunol (1980) 0.97
Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella intermedia over a 5-year period: effect of a triclosan/copolymer dentifrice. J Clin Periodontol (2003) 0.97
Bacterial endotoxin: a role in chronic inflammatory periodontal disease? J Oral Pathol (1980) 0.96
The reactivity of a monoclonal antibody against cells of the monocyte-macrophage series in sections of normal and inflamed human tissues. J Reticuloendothel Soc (1983) 0.96
The regulatory role of doxycycline/tetracycline in collagenolytic activity and tissue destruction in joint diseases: comment on the article by Yu et al. Arthritis Rheum (1993) 0.95
Gingival cell IL-2 and IL-4 in early-onset periodontitis. J Periodontol (1994) 0.95
Direct and indirect effects of Porphyromonas gingivalis lipopolysaccharide on interleukin-6 production by human gingival fibroblasts. Oral Microbiol Immunol (1992) 0.95
Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis. J Clin Periodontol (1979) 0.95
Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res (1998) 0.95
The identification of lymphoid cell subpopulations in sections of human lymphoid tissue and gingivitis in children using monoclonal antibodies. J Periodontal Res (1982) 0.94
Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol (2005) 0.94
Cytokine messenger RNA expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol (1997) 0.94
Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus? J Oral Pathol Med (1996) 0.94
Costimulatory molecules in human periodontal disease tissues. J Periodontal Res (2001) 0.93
Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res (1997) 0.93
The immunopathogenesis of progressive chronic inflammatory periodontal disease. J Oral Pathol (1979) 0.92
A longitudinal study of interleukin-1 gene polymorphisms and periodontal disease in a general adult population. J Clin Periodontol (2001) 0.92
Dental stem cells and their potential role in apexogenesis and apexification. Int Endod J (2009) 0.91
Immunohistochemical analysis of the human bladder. Br J Urol (1986) 0.91
Production of monoclonal antibodies that recognize specific and cross-reactive antigens of Fusobacterium nucleatum. Infect Immun (1987) 0.91
Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol (2002) 0.90
CD45RA and CD45RO positive CD4 cells in human peripheral blood and periodontal disease tissue before and after stimulation with periodontopathic bacteria. Oral Microbiol Immunol (1992) 0.90
A radiographic study of chronic periodontitis in 15 year old Queensland children. J Clin Periodontol (1983) 0.90
Experimental gingivitis in humans. A histochemical and immunological characterization of the lymphoid cell subpopulations. J Periodontal Res (1983) 0.90
Cytochemical identification of T and B cells in situ in mouse lymphoid tissue and lymph nodes from the rat, gerbil and cat. Ann Immunol (Paris) (1979) 0.89
Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcif Tissue Int (1997) 0.89
Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells. Clin Exp Immunol (1987) 0.89
Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model. J Periodontol (1998) 0.89
Microbiological and serological investigations of oral lesions in Papillon-Lefèvre syndrome. J Clin Pathol (1996) 0.89
Loss of Langerhans cells from gingival tissue maintained in organ culture. J Oral Pathol (1984) 0.89
The impact of periodontitis on oral health-related quality of life: a review of the evidence from observational studies. Aust Dent J (2013) 0.89
Patient-reported complications associated with Campylobacter jejuni infection. Epidemiol Infect (2009) 0.88
Interleukin 1, interleukin 6 and transforming growth factor-beta production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. J Periodontal Res (1993) 0.88
Interleukin-1 and interleukin-1 inhibitor production by human adherent cells stimulated with periodontopathic bacteria. Arch Oral Biol (1989) 0.88
High magnification in situ viewing of wound healing in oral mucosa. Aust Dent J (1996) 0.88
Association between plaque accumulation and Langerhans cell numbers in the oral epithelium of attached gingiva. J Clin Periodontol (1982) 0.88
Modulation of gingival Langerhans cell T6 antigen expression in vitro by interleukin 1 and an interleukin 1 inhibitor. Clin Exp Immunol (1986) 0.87
Modulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2. J Oral Pathol (1986) 0.87
Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J Periodontol (1987) 0.87
The effect of platelet-rich plasma on osteoblast and periodontal ligament cell migration, proliferation and differentiation. J Periodontal Res (2009) 0.87
The surface effect of dentifrices. Aust Dent J (2000) 0.86
Analysis of lymphocyte populations extracted from chronically inflamed human periodontal tissues. II. Blastogenic response. J Periodontal Res (1985) 0.86
The antimicrobial and clinical effects of a single subgingival irrigation of chlorhexidine in advanced periodontal lesions. J Clin Periodontol (1986) 0.86
Histological assessment of periodontally involved cementum. J Clin Periodontol (1982) 0.86
Decreased salivary immunoglobulin A secretion rate after intense interval exercise in elite kayakers. Eur J Appl Physiol Occup Physiol (1993) 0.86
Progression of periodontal disease and interleukin-10 gene polymorphism. J Periodontal Res (2008) 0.86
Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol (1994) 0.86
Selective expansion of T cells in gingival lesions of patients with chronic inflammatory periodontal disease. Clin Exp Immunol (2000) 0.86
Heat shock protein expression in oral epithelial dysplasia and squamous cell carcinoma. Eur J Cancer B Oral Oncol (1995) 0.86
Direct modulation of human neutrophil adherence by coaggregating periodontopathic bacteria. Int Arch Allergy Appl Immunol (1987) 0.85
Gamma delta T lymphocytes in human periodontal disease tissue. J Periodontol (1995) 0.85
High antibody levels to P. gingivalis in cardiovascular disease. J Dent Res (2010) 0.85
Oral mucosal Langerhans cells express DR and DQ antigens. J Dent Res (1986) 0.85
Heat shock protein expression in oral lichen planus. J Oral Pathol Med (1995) 0.85
Protective immunity to Porphyromonas gingivalis infection in a murine model. J Periodontol (1995) 0.85